Contribute to the zintro blog!
i write the zintro blog. I am looking for your expert opinion on the question below and a written response that is one to three paragraphs. Your response may be used in an article that i will write and post on the zintro site. If it is used, you will be named in the article and a link to your expert profile will be included. Your contribution is voluntary and provides you with a great marketing opportunity to get your name and expert opinion published. Here is a sample blog: http://blog.Zintro.Com/
question: the debt crises in the us and europe has created uncertainty in global debt markets. Are emerging countries a better choice? What is behind this shift toward emerging countries as a less risky choice than the us or europe?
If you are interested, please send me your response via znotes in the next day or two. If you have any questions, please let me know.
maureen aylward+10 Other Responses
Emerging Technologies In Oncology
Our client is interested in speaking with oncology key opinion leaders to better understand the future changes in imaging procedures and care pathways or patient journey centric.
Ideally, they are looking for leaders who can discuss the following technology segments: theranostics, personalized medicine (in-vitro diagnostics, genomics, proteomics, radiomics), and artificial intelligence.
An incentive of $400 will be paid to participants for a 1-hour phone interview.
Please provide a brief answer as to your relevance to the space below:
do you work in the us or european healthcare setting where patients with cancers (oncology) are treated?
Which best describes you?
Physician (md) - medical oncologist
physician (md) – surgical oncologist
physician (md) – radiation oncologist
clinical or organizational leadership - md (chief medical officer, chief innovation officer, cxo role)
certified physician assistant
advanced practice registered nurse (nurse practitioner, clinical nurse specialist, etc.)
others (please specify)
which of the following emerging technology areas are you familiar with in the context of oncology patient diagnostics and treatment?
A. Theranostics – imaging-related area pairing diagnostic and therapeutic agents
b. Artificial intelligence
c. Personalized medicine (including in-vitro diagnostics, genomics, proteomics, radiomics)
d. Diagnostic imaging - use of imaging modalities as part of patient diagnosis and care depending on cancer (e.G. Mri, ct, mammography, pet, spect, ixr, x-ray, ultrasound
please discuss briefly the current or future perspective on theranostics, personalized medicine (in-vitro diagnostics, genomics, proteomics, radiomics), artificial intelligence areas in terms of pain points, realized market usage, and growth.
*please note that we are only interested in your personal point of view and are not seeking confidential information.
**referrals are highly appreciated
+36 Other Responses
Legal Services & Debt Collection In Mexico
I am looking for expertise in the legal services and debt collection category with respect to certain insights on the legal market as to which are the top law firms and debt collection agencies in mexico providing legal recovery, legal corporate review services and debt collection services.
Legal recovery services include: mortgage, credit cards, payroll loans, cars and consumer loan services.
Legal corporate review services include review of legal documentation provided by clients to the bank.
Debt collection services include: mortgage, credit cards, payroll loans, cars and consumer loan services.
With respect to the above i would want insights on the following questions:
1) which are the law firms and debt collection agencies providing the aforementioned services?
2) what are the current payment models adopted by these law firms or debt collection agencies
- how many of them charge alternate fee arrangements? (example: fixed fee, capped fee, flat fee etc.)
- what do they charge as percentage of fee by stage of case and what is the percentage?
3) what is the alternative mechanisms of payment (example: payment made based on success of case, efficiency rate of performance, incentive based pricing etc.)
thanks and looking forward to your response.+3 Other Responses